Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,925 | 77 | 97.2% |
| Education | $55.39 | 4 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $870.41 | 41 | $0 (2020) |
| Teleflex LLC | $355.40 | 5 | $0 (2024) |
| NeoTract Inc. | $189.50 | 11 | $0 (2020) |
| PROCEPT BioRobotics Corporation | $120.46 | 2 | $0 (2020) |
| Coloplast Corp | $78.42 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $61.45 | 3 | $0 (2023) |
| Astellas Pharma US Inc | $56.78 | 3 | $0 (2021) |
| PFIZER INC. | $55.39 | 4 | $0 (2020) |
| NxThera, Inc. | $49.40 | 4 | $0 (2017) |
| BOSTON SCIENTIFIC CORPORATION | $47.13 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $196.17 | 3 | Teleflex LLC ($179.17) |
| 2023 | $214.07 | 5 | Teleflex LLC ($176.23) |
| 2022 | $23.61 | 1 | Janssen Biotech, Inc. ($23.61) |
| 2021 | $25.79 | 2 | Astellas Pharma US Inc ($14.53) |
| 2020 | $222.41 | 5 | Medtronic USA, Inc. ($102.39) |
| 2019 | $254.37 | 17 | Medtronic USA, Inc. ($122.86) |
| 2018 | $587.05 | 27 | Medtronic USA, Inc. ($369.17) |
| 2017 | $456.55 | 21 | Medtronic USA, Inc. ($275.99) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $169.76 | General |
| 05/16/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: UROTHELIAL CANCER | ||||||
| 03/11/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 12/07/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Oncology | ||||||
| 10/26/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: Interventional Urology | ||||||
| 09/20/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Oncology | ||||||
| 06/13/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $127.85 | General |
| Category: Interventional Urology | ||||||
| 06/13/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Interventional Urology | ||||||
| 03/16/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Oncology | ||||||
| 08/17/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: ONCOLOGY | ||||||
| 01/20/2021 | Olympus America Inc. | VISERA ELITE II VIDEO SYSTEM CENTER (Device) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Surgical Endoscopy | ||||||
| 07/29/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Interventional Urology | ||||||
| 03/04/2020 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 01/27/2020 | PROCEPT BioRobotics Corporation | AquaBeam Robotic System (Device) | Food and Beverage | In-kind items and services | $89.73 | General |
| Category: Urology | ||||||
| 01/23/2020 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $11.50 | General |
| Category: ONCOLOGY | ||||||
| 01/09/2020 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $84.66 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 12/14/2019 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/02/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Oncology | ||||||
| 08/01/2019 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 07/25/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $14.63 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2019 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $4.12 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 05/30/2019 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 05/23/2019 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 05/21/2019 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 05/21/2019 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: Sacral Nerve Stimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 7,457 | 53,898 | $4.6M | $875,675 |
| 2022 | 43 | 7,250 | 18,821 | $4.1M | $1.0M |
| 2021 | 43 | 7,689 | 43,840 | $4.5M | $1.1M |
| 2020 | 43 | 8,063 | 15,656 | $4.0M | $948,996 |
All Medicare Procedures & Services
170 procedure records from CMS Medicare Utilization — Page 6 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2021 | 281 | 336 | $3,360 | $487.14 | 14.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2021 | 50 | 256 | $2,560 | $108.29 | 4.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 1,148 | 1,803 | $667,110 | $168,620 | 25.3% |
| 76872 | Ultrasound of rectum | Office | 2020 | 1,056 | 1,388 | $638,480 | $163,658 | 25.6% |
| 76857 | Ultrasound of pelvis | Office | 2020 | 1,401 | 2,094 | $355,980 | $84,590 | 23.8% |
| 76775 | Ultrasound behind abdominal cavity, limited | Office | 2020 | 1,001 | 1,241 | $260,610 | $64,096 | 24.6% |
| 52442 | Insertion of implant in bladder canal (urethra) within prostate gland using an endoscope | Office | 2020 | 18 | 64 | $220,160 | $61,004 | 27.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 703 | 908 | $236,080 | $55,522 | 23.5% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 192 | 216 | $144,720 | $40,433 | 27.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2020 | 28 | 201 | $138,690 | $34,152 | 24.6% |
| 76770 | Ultrasound behind abdominal cavity | Office | 2020 | 246 | 253 | $97,500 | $26,819 | 27.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 203 | 203 | $111,650 | $26,599 | 23.8% |
| 52441 | Insertion of implant in bladder canal (urethra) within prostate gland using an endoscope | Office | 2020 | 18 | 18 | $81,720 | $23,471 | 28.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 23 | 4,401 | $217,555 | $21,344 | 9.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 176 | 262 | $63,154 | $16,330 | 25.9% |
| 52214 | Destruction of tissue in the bladder, bladder canal (urethra) or surrounding glands using an endoscope | Office | 2020 | 21 | 21 | $52,290 | $14,172 | 27.1% |
| 52224 | Destruction of (less than 0.5 centimeters) growths of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 18 | 19 | $49,400 | $13,515 | 27.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 99 | 103 | $46,350 | $12,076 | 26.1% |
| 52287 | Examination with injections of chemical for destruction of bladder using an endoscope | Office | 2020 | 23 | 38 | $44,840 | $12,047 | 26.9% |
| 52649 | Laser fragmentation of prostate tissue with control of bleeding using an endoscope | Facility | 2020 | 13 | 13 | $36,270 | $9,620 | 26.5% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2020 | 20 | 20 | $50,200 | $9,330 | 18.6% |
| 51741 | Electronic assessment of bladder emptying | Office | 2020 | 520 | 709 | $111,210 | $9,170 | 8.2% |
| 52310 | Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope | Office | 2020 | 32 | 35 | $32,550 | $9,098 | 28.0% |
| 52601 | Electro-removal of prostate through bladder canal (urethra) with control of bleeding using an endoscope | Facility | 2020 | 12 | 12 | $29,520 | $7,835 | 26.5% |
| 52281 | Dilation of bladder canal (urethra) using an endoscope | Office | 2020 | 23 | 27 | $28,080 | $7,559 | 26.9% |
About Dr. Alexander Kirshenbaum, MD
Dr. Alexander Kirshenbaum, MD is a Urology healthcare provider based in Freehold, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1447306345.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Kirshenbaum, MD has received a total of $1,980 in payments from pharmaceutical and medical device companies, with $196.17 received in 2024. These payments were reported across 81 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,925).
As a Medicare-enrolled provider, Kirshenbaum has provided services to 30,459 Medicare beneficiaries, totaling 132,215 services with total Medicare billing of $4.0M. Data is available for 4 years (2020–2023), covering 170 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Pediatric Urology
- Location Freehold, NJ
- Active Since 01/25/2007
- Last Updated 03/09/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1447306345
Products in Payments
- INTERSTIM (Device) $848.23
- UroLift (Device) $189.50
- UROLIFT (Device) $185.64
- AquaBeam Robotic System (Device) $120.46
- XTANDI (Drug) $92.84
- PENILE RECONSTRUCTION (Device) $78.42
- ERLEADA (Drug) $61.45
- Rezum (Device) $49.40
- GENERAL BPH (Device) $47.13
- Axumin (Drug) $33.41
- INTERSTIM ICON (Device) $22.18
- Xtandi (Drug) $19.33
- Xofigo (Drug) $19.01
- JELMYTO (Drug) $17.00
- Lupron Depot (Drug) $15.00
- VISERA ELITE II VIDEO SYSTEM CENTER (Device) $11.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Freehold
Dr. Matthew Pagano, Md, MD
Urology — Payments: $2,992
Dr. Doh Yoon Cha, M.d, M.D
Urology — Payments: $2,595
Dr. Arturo Canto, M.d, M.D
Urology — Payments: $1,475
Dr. Troy Sukkarieh, Md, MD
Urology — Payments: $1,457
Dr. Emad Rizkala, M.d, M.D
Urology — Payments: $1,152
Dr. William Kohlberg, M.d, M.D
Urology — Payments: $207.94